A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor

Moritz F Kircher1, Umar Mahmood, Raymond S King

  • 1Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA.

Cancer Research
|December 18, 2003
PubMed

Insights

This study introduces a multimodal nanoparticle for brain tumor margin delineation. The nanoparticle acts as both a preoperative MRI contrast agent and an intraoperative optical probe, improving surgical precision.

Area of Science:

  • Neuro-oncology
  • Nanomedicine
  • Biomedical Imaging

Background:

  • Accurate determination of brain tumor margins is critical for effective patient therapy.
  • Current methods for intraoperative margin assessment present significant challenges for neurosurgeons.

Purpose of the Study:

  • To explore a novel multimodal nanoparticle for enhanced brain tumor margin delineation.
  • To evaluate its utility as a preoperative MRI contrast agent and an intraoperative optical probe.

Main Methods:

  • Development and characterization of a near-infrared fluorescent and magnetic nanoparticle.
  • Utilizing a gliosarcoma rat model with green fluorescence protein-expressing glioma cells.
  • Assessing nanoparticle performance in preoperative MRI and intraoperative optical imaging.

Main Results:

  • The multimodal nanoparticle successfully delineated brain tumors via preoperative MRI.
  • Intraoperative optical imaging using the nanoparticle enabled precise tumor margin visualization.
  • Nanoparticle sequestration by microglia contributed to effective tumor delineation.

Conclusions:

  • Multimodal nanoparticles offer a promising approach for improving brain tumor margin definition.
  • This technology may enhance collaboration between radiologists and neurosurgeons.
  • The developed nanoparticle represents a new strategy for precise tumor resection.

Related Concept Videos